Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema

Method of identifying a PPARgamma-agonist compound having a decreased likelihood of inducing dose-dependent peripheral edema

US Patent 7482124 · Granted Jan 27, 2009

Estimated economic value: $62,964,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Methods of treating tumor2025
Methods of treating a tumor using an anti-PD-1 antibody2025
Methods of treating tumor2024
Genetic polymorphisms associated with cardiovascular disorders and drug response2023
Anti-PAD4 autoantibodies as clinical response biomarkers for the treatment of rh2023
Methods of treating a tumor using an anti-PD-1 antibody2023
CCL20 as a predictor of clinical response to IL23-antagonists2022
Prediction of clinical response to IL23-antagonists using IL23 pathway biomarker2021
Genetic polymorphisms associated with cardiovascular disorders and drug response2021
Methods of using antibodies to determine periostin levels in a sample2020
Recombinant polypeptide production2018
Genetic polymorphisms associated with cardiovascular disorders and drug response2018